e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Pleural and mediastinal malignancies: management and rare clinical cases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed
M. Lehmann, A. T. Kempa, F. Stanzel, M. Serke (Hemer, Germany)
Source:
Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Session:
Pleural and mediastinal malignancies: management and rare clinical cases
Session type:
Thematic Poster Session
Number:
2835
Disease area:
Interstitial lung diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lehmann, A. T. Kempa, F. Stanzel, M. Serke (Hemer, Germany). First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed. Eur Respir J 2011; 38: Suppl. 55, 2835
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The incidence of bronchiolitis obliterans organizing pneumonia syndrome after radiation therapy for breast cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001
Polychemotherapy experience in pleural mesothelioma with or without pemetrexed
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer
Source: Eur Respir J 2003; 21: 552-555
Year: 2003
Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004
Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Second-line chemotherapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002
Multiple and bilateral bronchiolitis obliterans organizing pneumonias following chemotherapy for primitive neuroectodermal tumor
Source: Eur Respir J 2005; 26: Suppl. 49, 173s
Year: 2005
Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003
Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions
Source: Eur Respir J 2004; 24: 263-266
Year: 2004
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
Systemic treatment of malignant mesothelioma
Source: Eur Respir Mon; 2009: 44: 419–434
Year: 2009
Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003
Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005
Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004
Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005
Experience of ozonotherapy in complex chemotherapy of acute nonspecific pleural empyema
Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices
Year: 2009
Chronic eosinophilic pneumonia after radiation therapy for breast cancer
Source: Eur Respir J 2004; 23: 9-13
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept